Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
NCT: NCT03067051 · RECRUITING
광고
NCT IDNCT03067051
상태RECRUITING
시작일2017-03-21
완료2027-12-31
간략 요약
The rationale for the study is to obtain safety and efficacy data as well as to establish dose parameters for the SpectraCure P18 System with IDOSE®, with verteporfin for injection (VFI) as photosensitizer for the treatment of recurrent prostate cancer.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.